ClinicalTrials.gg
CompletedNCT06683976Updated Jan 6, 2025

Evaluating Improvised Chest Drainage Techniques in Conflict Zones

An observational study in Pneumothorax, Hemothorax and Thoracic Trauma, sponsored by Sudan Medical Specialization Board. Completed at 1 site in Sudan. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-01-06.

Sponsored by Sudan Medical Specialization Board · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
180
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This study examines the use of improvised chest drainage systems in managing chest trauma at Wad Madani Teaching Hospital, a low-resource and conflict-affected setting. Due to a shortage of standard chest tubes and underwater seal systems, healthcare providers have adapted by using nasogastric (NG) tubes as chest drains and IV drip sets as makeshift underwater seals.

The study aims to evaluate the safety, effectiveness, and feasibility of these improvised methods compared to traditional chest drainage techniques. Primary outcomes will include lung re-expansion success, infection rates, and hospital stay length. By assessing patient outcomes, this study seeks to determine if these adapted techniques can provide a viable alternative for trauma care in resource-limited settings, potentially guiding practices in similar environments globally.

Read the detailed description

This study explores the application of improvised chest drainage systems at Wad Manani Teaching Hospital for managing chest trauma in a low-resource, conflict-affected setting. Due to limited availability of standard medical supplies, an alternative approach has been adopted using nasogastric (NG) tubes as chest drains paired with intravenous (IV) drip sets, modified to act as underwater seals.

The primary aim is to assess the safety and effectiveness of these improvised systems in comparison to conventional chest tube drainage. By focusing on outcomes such as lung re-expansion success, infection rates, and recovery time, this study seeks to establish the clinical viability of improvised drainage systems in emergencies. Secondary evaluations include cost-effectiveness and the role of targeted staff training in improving procedural outcomes.

Study Approach:

This is a 6-months prospective observational study where patients with chest injuries are assigned to either a standard treatment group or an improvised treatment group. The improvised system involves inserting an NG tube as a chest drain connected to a modified IV drip set for underwater sealing. Standard sterile protocols are followed to reduce infection risk.

Data Collection \& Analysis:

Data on each patient's clinical course and intervention will be recorded, focusing on primary outcomes like successful lung re-expansion and infection, and secondary outcomes, including procedural feasibility and cost. Comparative statistical analysis will assess outcome differences between groups.

Ethical Compliance:

Institutional review board (IRB) approval will be obtained, with all patient data anonymized and securely stored. Informed consent will be obtained from all participants or their guardians.

Impact Statement:

By assessing improvised methods in trauma care within a resource-limited context, this study could inform adaptable practices for similar environments worldwide, potentially influencing trauma care protocols and patient outcomes in challenging settings.

02

Conditions studied

  • Pneumothorax
  • Hemothorax
  • Thoracic Trauma
  • Flail Chest
  • Hemopneumothorax; Traumatic

Keywords

  • Underwater Seal System Alternatives
  • Chest Trauma
  • Improvised Chest Drainage
  • Nasogastric Tube Chest Drain
  • Low-Resource Trauma Care
  • Conflict Zone Healthcare
  • Pneumothorax Management
  • Hemothorax Treatment
  • Alternative Chest Tube Methods
  • Emergency Thoracic Intervention
03

In context

Pneumothorax

183 studies on the registry are indexed under Pneumothorax; 41 are open to participants now.

This study's enrollment of 180 is above the median of 157 across 66 observational studies indexed under Pneumothorax.

Browse Pneumothorax studies →

Lead sponsor

Sudan Medical Specialization Board is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study will include adult patients (18 years and75 years) presenting with chest trauma at Wad Madani Teaching Hospital, a low-resource and conflict-affected setting. Patients are eligible if they require chest drainage for conditions such as pneumothorax or hemothorax and are stable enough to undergo the procedure. Due to limited resources, chest drainage methods include both standard and improvised techniques. The study population represents individuals receiving trauma care in a low-resource setting, providing insights into the effectiveness and safety of adapted drainage techniques in resource-constrained environments

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years and older
  • Patients presenting with chest trauma requiring chest drainage (e.g., pneumothorax, hemothorax)
  • Willingness to provide to participate in the study -Stable enough to undergo chest X-ray or clinical assessment for lung re- expansion

Exclusion criteria

Exclusion Criteria:

  • Patients with pre-existing severe lung disease or significant comorbidities affecting chest drainage outcomes (e.g., advanced , heart failure)
  • Patients with prior chest surgery that may interfere with drainage outcomes
  • Individuals with to chest tube insertion or NG tube placement
  • Patients unwilling or unable to provide
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
180 participants (actual)
Target follow-up
2 Months
Patient registry
Yes

Groups and cohorts

  • Standard Treatment Group Label: Conventional Chest Drainage

    This group includes patients with chest trauma who receive standard chest drainage using commercial chest tubes and underwater seal systems. This intervention follows established guidelines and protocols for chest drainage in trauma care. Patients in this group serve as the control group for comparing outcomes with those receiving improvised drainage systems.

  • Improvised Treatment Group Label: Improvised NG Tube Drainage

    This group includes patients with chest trauma who receive chest drainage using improvised methods, specifically nasogastric (NG) tubes as chest drains and intravenous (IV) drip sets adapted to function as underwater seals. This alternative intervention is used due to resource constraints and aims to evaluate the safety and effectiveness of improvised methods in a low-resource, conflict-affected setting

06

What researchers measure

Primary outcomes

  1. Percentage of Patients With Successful Lung Re-expansion

    The percentage of patients in each group (conventional vs. improvised chest drainage) who achieve full lung re-expansion as confirmed by chest X-ray.

    Time frame: Within 72 hours post-drainage

Secondary outcomes

  1. Rate of Drainage-Related Infections

    Number of participants with infections directly associated with the chest drainage procedure, including pleural or wound infections, documented by clinical signs and laboratory findings.

    Time frame: Up to 30 days post-procedure

  2. Median Length of Hospital Stay

    Median number of days from admission to discharge for each participant, allowing for the assessment of recovery duration associated with each drainage method.

    Time frame: From admission to discharge (typically within 30 days)

Other outcomes

  1. Patient Satisfaction Score at Discharge

    Patient satisfaction score assessed using a 5-point Likert scale (1 = very dissatisfied, 5 = very satisfied) at discharge, indicating the participant's perceived comfort and effectiveness of the chest drainage method used.

    Time frame: At discharge (up to 30 days post-procedure)

07

Study locations

1 site
  • Wad Madani teaching Hospital
    Wad Madani, Gezira, Sudan
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared publicly due to several considerations. First, the data includes sensitive personal health information, which must be protected to comply with privacy regulations and ethical standards. Additionally, the study is conducted in a low-resource setting, where data management and sharing capabilities may be limited. Ensuring the confidentiality and anonymity of participants is paramount, and sharing IPD could compromise these ethical obligations. Finally, the data will be used exclusively for the purpose of this study to inform clinical practice within the context of the local healthcare system, rather than for broader dissemination.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06683976
Lead sponsor
Sudan Medical Specialization Board
Responsible party
Alsadig Suliman (Principal Investigator, Sudan Medical Specialization Board) — Principal investigator
First posted
Nov 12, 2024
Start date
Jun 1, 2023
Primary completion
Dec 1, 2023
Completion
Dec 10, 2023
Last update
Jan 6, 2025

Study contacts

Hassan Ali Musa, Consultant
study chair · University of Gezira, Faculty of medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion